Lataa...
Six-Month Open-Label Follow-Up of Risperidone Long-Acting Injection Use in Pediatric Bipolar Disorder
Background: Recent studies suggest that risperidone long-acting injection (RLAI) may be considered for controlling mood episodes in bipolar disorder patients who have relapsed due to medication nonadherence or failure to respond to standard therapies. Currently, no study has reported the usefulness...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Physicians Postgraduate Press, Inc.
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3795581/ https://ncbi.nlm.nih.gov/pubmed/24171144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.12m01368 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|